These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38515580)

  • 41. Oral administration of apigenin inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model.
    He J; Xu Q; Wang M; Li C; Qian X; Shi Z; Liu LZ; Jiang BH
    Int J Mol Sci; 2012; 13(6):7271-7282. PubMed ID: 22837693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
    Khan S; Shukla S; Sinha S; Lakra AD; Bora HK; Meeran SM
    Int J Biochem Cell Biol; 2015 Jan; 58():1-16. PubMed ID: 25448414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer Metastasis.
    Buyuk B; Jin S; Ye K
    Cell Mol Bioeng; 2022 Feb; 15(1):1-13. PubMed ID: 35096183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clerodendrum petasites S. Moore: The therapeutic potential of phytochemicals, hispidulin, vanillic acid, verbascoside, and apigenin.
    Brimson JM; Onlamoon N; Tencomnao T; Thitilertdecha P
    Biomed Pharmacother; 2019 Oct; 118():109319. PubMed ID: 31404773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals.
    Illam SP; Narayanankutty A; Mathew SE; Valsalakumari R; Jacob RM; Raghavamenon AC
    Recent Pat Anticancer Drug Discov; 2017; 12(3):234-246. PubMed ID: 28440207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apigenin in cancer therapy: From mechanism of action to nano-therapeutic agent.
    Zhou Y; Yu Y; Lv H; Zhang H; Liang T; Zhou G; Huang L; Tian Y; Liang W
    Food Chem Toxicol; 2022 Oct; 168():113385. PubMed ID: 36007853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apigenin and its impact on gastrointestinal cancers.
    Lefort ÉC; Blay J
    Mol Nutr Food Res; 2013 Jan; 57(1):126-44. PubMed ID: 23197449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition.
    Yang Z; Garcia A; Xu S; Powell DR; Vertino PM; Singh S; Marcus AI
    PLoS One; 2013; 8(9):e75069. PubMed ID: 24069380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
    Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.
    Park J; Jeong D; Song M; Kim B
    Antioxidants (Basel); 2021 Mar; 10(4):. PubMed ID: 33801741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlling metastatic cancer: the role of phytochemicals in cell signaling.
    Kapinova A; Kubatka P; Liskova A; Baranenko D; Kruzliak P; Matta M; Büsselberg D; Malicherova B; Zulli A; Kwon TK; Jezkova E; Blahutova D; Zubor P; Danko J
    J Cancer Res Clin Oncol; 2019 May; 145(5):1087-1109. PubMed ID: 30903319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isoimperatorin down-regulates epithelial mesenchymal transition through modulating NF-κB signaling and CXCR4 expression in colorectal and hepatocellular carcinoma cells.
    Kim NY; Jung YY; Yang MH; Um JY; Sethi G; Ahn KS
    Cell Signal; 2022 Nov; 99():110433. PubMed ID: 35934221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway.
    Hou CH; Lin FL; Hou SM; Liu JF
    Mol Cancer; 2014 Oct; 13():236. PubMed ID: 25326651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.
    Rumman M; Jung KH; Fang Z; Yan HH; Son MK; Kim SJ; Kim J; Park JH; Lim JH; Hong S; Hong SS
    Oncotarget; 2016 Nov; 7(47):78029-78047. PubMed ID: 27793006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms.
    Ge H; Xu C; Chen H; Liu L; Zhang L; Wu C; Lu Y; Yao Q
    Front Pharmacol; 2022; 13():842295. PubMed ID: 35308223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apigenin regulates the migration, invasion, and autophagy of hepatocellular carcinoma cells by downregulating YAP.
    Zeng J; Xie H; Zhang ZL; Li ZX; Shi L; Wu KY; Zhou Y; Tian Z; Zhang Y; Zhou W; Shen WG
    Neoplasma; 2022 Mar; 69(2):292-302. PubMed ID: 35014535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K/Akt/mTOR signaling pathway.
    Li CY; Wang Q; Wang X; Li G; Shen S; Wei X
    Eur J Pharmacol; 2019 Sep; 858():172463. PubMed ID: 31211986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.